Birmingham-based corporate finance firm Cattaneo has played a key role in the sale of medical diagnostic products supplier Mediwatch to Canadian outfit Laborie Medical Technologies in an £8.5 million transaction.
It is the third international deal brokered by Cattaneo in the past month.
Mediwatch, which is headquartered in Rugby and has an operation in West Palm Beach, Florida, is a manufacturer of high-technology urology and gastro-intestinal equipment.
Brian Ellacott, chief executive of Laborie, said: “We believe that combining Mediwatch’s product portfolio with Laborie’s R&D capabilities and sales network will enable us to better serve physicians and hospitals around the world. ”
Mark Hughes, chief financial officer at Mediwatch, said: “Charles Cattaneo’s corporate finance skills were invaluable to us as a board in guiding us through the sale process under the takeover code.
“Having someone working alongside the board with a detailed knowledge of the business as well as many years of experience in corporate finance transactions was hugely helpful in managing the process effectively.”
Mediwatch was advised by David Facey, Katy Birkin and Liz Yong, all of SP Angel, and legal advice was provided by Amerjit Kalirai, of Field Fisher Waterhouse.
Laborie were advised by Daniel Adams, of Investec, with legal advice provided by Christian Lowis and Daniel O’Gorman, of DWF in Birmingham.
